Weigao blood purification sprint to Hong Kong: annual revenue of RMB 2.9 billion, net profit decreased by 12.7%

RedI network Lei Jianping 6 month 28 Reported Wednesday

Shandong Weigao blood purification products Co., Ltd （ abbreviation ：“ Weigao blood purification ”） The prospectus was submitted a few days ago , Ready to list in Hong Kong .

Weigao blood purification is ESRD Patients are provided with full cycle treatment mode of hemodialysis and peritoneal dialysis . Wego blood purification provides comprehensive blood purification products , Including dialyzer 、 Dialysis machine 、 Hemodialysis products such as blood pipelines and peritoneal dialysis products such as peritoneal dialysis fluid .

The prospectus shows , Weigao blood purification 2019 year 、2020 year 、2021 The annual revenue is 22 One hundred million yuan 、25.65 One hundred million yuan 、29.48 One hundred million yuan ; The gross profit is 10.7 One hundred million yuan 、12.65 One hundred million yuan 、13.53 One hundred million yuan , The gross profit rates are 48.6%、49.3%、45.9%.

Weigao blood purification 2019 year 、2020 year 、2021 The profit during the year was 1.96 One hundred million yuan 、3.08 One hundred million yuan 、2.69 One hundred million yuan ; The profit margins during the year were 9%、12%、9.1%.

Weigao blood purification 2021 The net profit in the year was lower than that in the same period of the previous year 12.66%.

The executive directors of wego blood purification are songxiushan 、 Zhangcunming 、 Ms. chenxiaoyun 、 Wang Ji 、 Dr. muqijun ; The non-executive directors are tangzhengpeng ;

The independent non-executive directors of wego blood purification are zhangsenquan 、 Liu Erfei 、 Dr. songxiliang .

IPO front , The shares held by Weigao group are 46.39%, Weigao medical polymer Co., Ltd 26.55%, Weihai Kaide has a shareholding of 10.76%, The shareholding of Jizhuang is 2.83%.

———————————————

Lei Di was founded by Lei Jianping, a senior media person , If reproduced, please indicate the source .